Merck

Company www.merck.com ● Covered in 3 stories + Follow ✴ AI Graph

Merck describes itself as a research-intensive biopharmaceutical company focused on the development of medicines and vaccines. On its website, it presents areas including research, patients (information to guide health journeys), investors (financials, events, presentations, news, and stock information), and sustainability. It also highlights innovation via topics such as individualized neoantigen therapies, and provides a pipeline and clinical trials resources, along with media and contact information. The site states that Merck has been developing important medicines and vaccines for more than 130 years, and includes forward-looking statement language about pipeline and commercial outcomes being subject to risks and uncertainties.

Updated 9 September 2026

Public sources: Official website

Signals

—

Media momentum

As of 19 Oct 2026 · Visible stories in the last 30 days, compared with the 30 days before.

3 sources

Source diversity

As of 19 Oct 2026 · Distinct publications behind this entity's visible coverage.

—

Release activity

As of 19 Oct 2026 · Model, product and open-source release events in the last 90 days whose coverage involves this entity.

—

Funding signals

As of 19 Oct 2026 · Funding and acquisition events in the last 90 days whose coverage involves this entity.

Jul 2026 → Aug 2026

Coverage span

As of 19 Oct 2026 · First to most recent month of TLDRocket coverage of this entity.

Management

updated 5 Aug 2026

Robert M. Davis President & CEO
Sanat Chattopadhyay EVP & President, Merck Manufacturing Division
Beth Perrone Senior Vice President, Chief Talent & Strategy Officer
Fran Geatens Chief Technology Officer & Senior Vice President
Brian Foard Executive vice president and president, Specialty, Pharma & Infectious Diseases
Richard R. DeLuca Jr. EVP & President, Merck Animal Health
Jennifer Zachary EVP, General Counsel & Corporate Secretary
Gregg Szabo Senior Vice President, Merck, And President, Global Vaccines & Infectious Diseases
Ellen Lambert Exec VP Merck Company Foundation
Chirfi Guindo Executive Vice President, Strategic Access, Policy & Communications; Member of the Executive Team
Richard DeLuca Executive Vice President and President Animal Health
Jannie Oosthuizen President Global Oncology & MSD International